CIFLOXINAL
500MG TBL FLM 10
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Interruption of marketing | 21.12.2022 |
0096039 |
Manufacturing reasons | 27.02.2023 |
Resumption of marketing | 10.10.2022 | |||
Interruption of marketing | 09.09.2022 |
0096039 |
Manufacturing reasons | 14.10.2022 |
Resumption of marketing | 03.06.2019 | |||
Interruption of marketing | 26.04.2019 |
0096039 |
Capacity/distribution reasons | 07/2019 |
Resumption of marketing | 07.03.2019 | |||
Interruption of marketing | 21.12.2018 |
0087104 lék je nahraditelný případně jinou silou |
Capacity/distribution reasons | únor 2019 |
Resumption of marketing | 19.12.2018 | |||
Interruption of marketing | 16.11.2018 |
0096039 |
Capacity/distribution reasons | 19.12.2018 |
Resumption of marketing | 01.11.2018 | |||
Interruption of marketing | 10.10.2018 | Obtížně nahraditelný přípravkem Ciprinol vzhledem k nízkým dodávkám LP Ciprinol, případně LP s léčivou látkou ofloxacin (Ofloxin 200), s výjimkou pseudomonádových infekcí | Manufacturing reasons | 7.11.2018 |
Resumption of marketing | 24.09.2018 | |||
Interruption of marketing | 23.07.2018 |
0087104, 0094453, 0096039 |
||
Resumption of marketing | 09.08.2017 | |||
Interruption of marketing | 03.07.2017 |
0087104, 0094453, 0096039 |
||
Placing on the market | 01.12.2009 |
All reports are available in the Overview.